Cladribine Personalised Dosing to Treat Active Multiple Sclerosis - Follow-up in 250 patients

Abstract

This is the accepted manuscript of an article published online: 1. ACTRIMS Forum 2021 – Poster Presentations. Multiple Sclerosis Journal. 2021;27(1_suppl):15-122. doi:10.1177/1352458521101590

    Similar works